|
1
|
Xiang M, Su H, Shu G, Wan D, He F, Loaec
M, Ding Y, Li J, Dovat S, Yang G and Song C: Amplexicaule A exerts
anti-tumor effects by inducing apoptosis in human breast cancer.
Oncotarget. 7:18521–18530. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Early Breast Cancer Trialists'
Collaborative Group (EBCTCG), . Peto R, Davies C, Godwin J, Gray R,
Pan HC, Clarke M, Cutter D, Darby S, McGale P, et al: Comparisons
between different polychemotherapy regimens for early breast
cancer: Meta-analyses of long-term outcome among 100,000 women in
123 randomised trials. Lancet. 379:432–444. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zeng H, Zheng R, Zhang S, Zou X and Chen
W: Female breast cancer statistics of 2010 in China: Estimates
based on data from 145 population-based cancer registries. J Thorac
Dis. 6:466–470. 2014.PubMed/NCBI
|
|
4
|
Azim HA Jr, de Azambuja E, Colozza M,
Bines J and Piccart MJ: Long-term toxic effects of adjuvant
chemotherapy in breast cancer. Ann Oncol. 22:1939–1947. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
EBCTCG (Early Breast Cancer Trialists'
Collaborative Group), . McGale P, Taylor C, Correa C, Cutter D,
Duane F, Ewertz M, Gray R, Mannu G, Peto R, et al: Effect of
radiotherapy after mastectomy and axillary surgery on 10-year
recurrence and 20-year breast cancer mortality: Meta-analysis of
individual patient data for 8135 women in 22 randomised trials.
Lancet. 383:2127–2135. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang XL, Tao L, Zhou XL, Wei H and Sun JW:
Initial experience of automated breast volume scanning (ABVS) and
ultrasound elastography in predicting breast cancer subtypes and
staging. Breast. 30:130–135. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Selli C, Dixon JM and Sims AH: Accurate
prediction of response to endocrine therapy in breast cancer
patients: Current and future biomarkers. Breast Cancer Res.
18:1182016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Andree C, Schmidt VJ, Munder BIJ,
Seidenstücker K, Behrendt P, Witzel C, Horch RE, Andrews BT and
Richrath P: Detecting of breast cancer metastasis by means of
regional lymph node sampling during autologous breast
reconstruction-a screening of 519 consecutive patients. Med Sci
Monit. 18:CR605–CR610. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nicolini A, Ferrari P and Duffy MJ:
Prognostic and predictive biomarkers in breast cnacer: Past,
present and future. Semin Cancer Biol pii. 2017.(Epub ahead of
print). View Article : Google Scholar
|
|
10
|
Thomas C and Gustafsson JA: The different
roles of ER subtypes in cancer biology and therapy. Nat Rev Cancer.
11:597–608. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lehmann M, Pirinen E, Mirsaidi A, Kunze
FA, Richards PJ, Auwerx J and Hottiger MO: ARTD1-induced
poly-ADP-ribose formation enhances PPARγ ligand binding and
co-factor exchange. Nucleic Acids Res. 43:129–142. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Qin WD, Liu GL, Wang J, Wang H, Zhang JN,
Zhang F, Ma Y, Ji XY, Li C and Zhang MX: Poly(ADP-ribose)
polymerase 1 inhibition protects cardiomyocytes from inflammation
and apoptosis in diabetic cardiomyopathy. Oncotarget.
7:35618–35631. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Iwata H, Goettsch C, Sharma A, Ricchiuto
P, Goh WW, Halu A, Yamada I, Yoshida H, Hara T, Wei M, et al: PARP9
and PARP14 cross-regulate macrophage activation via STAT1
ADP-ribosylation. Nat Commun. 7:128492016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Juszczynski P, Kutok JL, Li C, Mitra J,
Aguiar RC and Shipp MA: BAL1 and BBAP are regulated by a gamma
interferon-responsive bidirectional promoter and are overexpressed
in diffuse large B-cell lymphomas with a prominent inflammatory
infiltrate. Mol Cell Biol. 26:5348–5359. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bachmann SB, Frommel SC, Camicia R,
Winkler HC, Santoro R and Hassa PO: DTX3L and ARTD9 inhibit IRF1
expression and mediate in cooperation with ARTD8 survival and
proliferation of metastatic prostate cancer cells. Mol Cancer.
13:1252014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou X, Tan M, Hawthorne VS, Klos KS, Lan
KH, Yang Y, Yang W, Smith TL, Shi D and Yu D: Activation of the
Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2
overexpression predicts tumor progression in breast cancers. Cancer
Res. 10:6779–6788. 2004.
|
|
17
|
Yin Y, Hua H, Li M, Liu S, Kong Q, Shao T,
Wang Y, Luo Q, Wang J, Luo T and Jiang Y: mTORC2 promotes type I
insulin-like growth factor receptor and insulin receptor activation
through the tyrosine kinase activity of mTOR. Cell Res. 26:46–65.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Camicia R, Bachmann SB, Winkler HC, Beer
M, Tinguely M, Haralambieva E and Hassa PO: BAL1/ARTD9 represses
the anti-proliferative and pro-apoptotic IFNgamma-STAT1-IRF1-p53
axis in diffuse large B-cell lymphoma. J Cell Sci. 126:1969–1980.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Y, Mao D, Roswit WT, Jin X, Patel
AC, Patel DA, Agapov E, Wang Z, Tidwell RM, Atkinson JJ, et al:
PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C
protease to enhance interferon signaling and control viral
infection. Nat Immunol. 16:1215–1227. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Greenwood C, Metodieva G, Al-Janabi K,
Lausen B, Alldridge L, Leng L, Bucala R, Fernandez N and Metodiev
MV: Stat1 and CD74 overexpression is co-dependent and linked to
increased invasion and lymph node metastasis in triple-negative
breast cancer. J Proteomics. 75:3031–3040. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yan Q, Xu R, Zhu L, Cheng X, Wang Z, Manis
J and Shipp MA: BAL1 and its partner E3 ligase, BBAP, link
poly(ADP-ribose) activation, ubiquitylation, and double-strand DNA
repair independent of ATM, MDC1, and RNF8. Mol Cell Biol.
33:845–857. 2013. View Article : Google Scholar : PubMed/NCBI
|
